CMO Jonathan Mark sold 10,000 VCEL shares at $58.72 on 2024-12-02; holds 58,371 shares post-sale.
Jonathan Mark, Chief Medical Officer of Vericel Corp, sold 10,000 shares (10.0K shares) for $587,200.00 on 2024-12-02 at $58.72, reducing his holdings by 14.6% to 58,371 shares. The sale occurred near the 52-week high of $59.11 (-1.5% from peak), following a strong 30-day appreciation of +32.4%. Vericel remains unprofitable on a full-year basis (net income was negative), though the company showed robust annual revenue growth of +20.2% and generated $57,905,000.00 in latest-quarter revenue. The timing of this reduction in an executive's stake while the stock trades near yearly highs, coupled with the company's ongoing net losses despite revenue expansion, presents a datapoint worth monitoring in the context of the company's path to profitability.